Navigation Links
Amarin to Present at Two Upcoming Investor Conferences
Date:2/22/2011

MYSTIC, Conn. and DUBLIN, Feb 22, 2011 Amarin Corporation plc (Nasdaq: AMRN) today announced that members of its senior management team will be presenting at two investor conferences on March 2, 2011.

Joseph Zakrzewski, Executive Chairman and Chief Executive Officer, is scheduled to present at the CITI 2011 Global Healthcare Conference on Wednesday, March 2, 2011 at 2:00 pm ET. This conference will be held at the Hilton New York City. A live audio webcast of the presentation will be available at http://www.veracast.com/webcasts/citigroup/healthcare2011/75211419.cfm.

John Thero, President, is scheduled to present at the RBC Capital Markets' Healthcare Conference on Wednesday, March 2, 2011 at 4:35 pm ET. This conference will be held at the New York Palace Hotel in New York City. A live audio webcast of the presentation will be available at http://www.wsw.com/webcast/rbc129/amrn.

About AmarinAmarin Corporation plc is a clinical-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. The Company's lead product candidate is AMR101 (icosapent ethyl, formerly called ethyl icosapentate). On November 29, 2010, the Company reported positive, statistically significant top-line results from the MARINE trial, the first of its Phase 3 clinical trials of AMR101. In the MARINE trial, AMR101 was investigated as a treatment for very high triglycerides (>500 mg/dL). AMR101 is presently being investigated in a second Phase 3 clinical trial, the ANCHOR trial, for the treatment of patients on statin therapy with high triglycerides (≥200 and <500mg/dL) with mixed dyslipidemia. The MARINE trial was, and the ANCHOR trial currently is, conducted under Special Protocol Assessme
'/>"/>

SOURCE Amarin Corporation plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
2. Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
3. Amarin to Present at UBS Life Sciences Conference
4. Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010
5. Amarin to Present at Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
6. Amarin Prices Public Offering of American Depositary Shares
7. Amarin Announces Underwriters Exercise of Over-Allotment Option
8. Amarin Announces Successful Completion of Offering of American Depositary Shares
9. Amarin Provides 2010 Year-End Review to Shareholders
10. Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... cancers and women,s health, has appointed Holly B. ... Markets. Ms. Bauzon has a proven track ... coverage for laboratory services companies. She has more than ... Inc., where she held the position of Director, Lab ...
(Date:8/21/2014)... - Eisai Limited is pleased to support the Canadian Epilepsy ... available in Canada . The comic book, ... children and their parents about epilepsy, the most common neurological ... 300,000 Canadians. Eisai is guided by a corporate philosophy known ... patient is central – there was a need within the ...
(Date:8/21/2014)... MISSION, Kan. , Aug. 21, 2014 /PRNewswire-iReach/ ... Information Trust Alliance (HITRUST) under its Common Security ... ScriptPro,s Enterprise Security and Privacy Manager, "We appreciate ... the level of commitment that this certification signifies. ... compliant." ABOUT THE CSF CERTIFICATION PROCESS: ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2ScriptPro Achieves HITRUST Certification 2
... REDWOOD CITY, Calif., Oct. 19 Ingenuity® Systems, ... science researchers, and TransMed Systems, a translational medicine ... between IPA® software and XB Bio-Integration Suite (XB-BIS). ... data that is managed and statistically analyzed by ...
... Results From the Intermezzo® Highway Driving Study -- POINT RICHMOND, Calif., Oct. 19 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // ...
Cached Medicine Technology:Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 2Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 3Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 4Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 5Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 6Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 7Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 8Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 9Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 10Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 11Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 12Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 13Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study 14
(Date:8/21/2014)... (PRWEB) August 22, 2014 Recently, iFitDress.com, a ... gowns, has updated its website with a new range of ... the company’s marketing specialist has announced that all these fashionable ... off. , The marketing specialist says, “We are very ... the moment, we are providing a wide variety of fashionable ...
(Date:8/21/2014)... 22, 2014 DoudouneCanadienneGoosePasCher.fr, one of the ... has recently unveiled its new selection of Trillium Parkas ... announced that all these fashionable and comfortable items are ... special offer will last until September 01. , ... the new Canada Goose Trillium Parkas for ...
(Date:8/21/2014)... 2014 Top10BestSEOHosting.com has recently compared ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one of the ... , The manager of Top10BestSEOHosting.com states, “It is ... Actually, these companies have outperformed their competitors on ... People can get the best web hosting at ...
(Date:8/21/2014)... 21, 2014 Today, Zane Benefits, the ... the premium tax credits in 2015. , According to ... part of the Affordable Care Act (ACA), premium tax ... individual health insurance through the Health Insurance Marketplaces. , ... and the amount of the tax credits, updated for ...
(Date:8/21/2014)... Corona, NY (PRWEB) August 21, 2014 ... new trend among their patients. Alternative medicine is ... to due to millenials. According to The Fiscal ... alternative medical treatments over conventional medicine. , The ... discussing how many millenials are embracing alternative medicine. ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Cheap Plus Size Evening Dresses for 2014 Now Available 2Health News:Fashionable And Comfortable Canada Goose Trillium Parkas For Sale At DoudouneCanadienneGoosePasCher.fr 2Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Van Uden Center Sees Growth in Alternative Medicine 2
... active antiretroviral treatment (HAART) needs to be careful// ... Belgium. ,Highly active antiretroviral treatment can dramatically ... expectancy. This is especially helpful for patients with ... to have a full commitment to the antiviral ...
... neck cancer who are undergoing radiation// therapy can now ... ,Oropharyngeal candidiasis is a fungal infection in the ... also called thrush. The symptoms of the disease are ... when removed leaves a bleeding surface. This is a ...
... often had complained of a sudden increase in weight, especially ... this sudden influx of weight often results in obesity that ... rise in type 2 diabetes cases, cardiovascular diseases and other ... may be due to a drop in the estrogen levels ...
... had affected a total of 423 cases in Angola,// which ... the form of a vaccine. ,A virus causes Marburg ... Ebola hemorrhagic fever. The disease is a rare condition but ... symptoms begin with severe headaches and feeling of severe unwell. ...
... intake of vitamin B may be at less risk from ... of alcohol along with vitamin B may have even reduced ... happens when there is growth of abnormal or malignant cells ... was done by Swedish and American researchers, said that inadequate ...
... an injury to the knee. This may lead to inflammations ... identified a way to find out how much loss of ... in order to find out whether the injury may be ... considered to be a risk factor for arthritis, it was ...
Cached Medicine News:
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity....
Medicine Products: